|
| Exchange Disseminated Time 28/09/2015 18:09:35 | Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on September 28, 2015, inter alia, transacted the following business:
Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to Shri JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI (ICDR) Regulation 2009. In terms of their issue the warrants are convertible into equity shares within the period of 18 months from the date of allotment. |
|
|